As of Nov 27
| +0.10 / +1.02%|
The 6 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 30.00 and a low estimate of 13.00. The median estimate represents a +71.37% increase from the last price of 9.92.
The current consensus among 6 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.